
### [NCIT:C136707](http://purl.obolibrary.org/obo/NCIT_C136707)
**Label:** Soft Tissue Sarcoma by AJCC v7 Stage

**Subclasses:** [NCIT:C6538](http://purl.obolibrary.org/obo/NCIT_C6538) (Stage II Soft Tissue Sarcoma AJCC v7), [NCIT:C6537](http://purl.obolibrary.org/obo/NCIT_C6537) (Stage I Soft Tissue Sarcoma AJCC v7), [NCIT:C7821](http://purl.obolibrary.org/obo/NCIT_C7821) (Stage IV Adult Soft Tissue Sarcoma AJCC v7), [NCIT:C4334](http://purl.obolibrary.org/obo/NCIT_C4334) (Meningeal Sarcomatosis), [NCIT:C7820](http://purl.obolibrary.org/obo/NCIT_C7820) (Stage III Adult Soft Tissue Sarcoma AJCC v7), [NCIT:C8586](http://purl.obolibrary.org/obo/NCIT_C8586) (Stage IV Soft Tissue Sarcoma AJCC v7), [NCIT:C4243](http://purl.obolibrary.org/obo/NCIT_C4243) (Sarcomatosis), [NCIT:C7818](http://purl.obolibrary.org/obo/NCIT_C7818) (Stage I Adult Soft Tissue Sarcoma AJCC v7), [NCIT:C8585](http://purl.obolibrary.org/obo/NCIT_C8585) (Stage III Soft Tissue Sarcoma AJCC v7), [NCIT:C7819](http://purl.obolibrary.org/obo/NCIT_C7819) (Stage II Adult Soft Tissue Sarcoma AJCC v7), 

**Class expressions from DL-Learner:**

- [UBERON:0009853](http://purl.obolibrary.org/obo/UBERON_0009853) (body of uterus) 54.17%
- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 54.17%
- Thing 52.77%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 39.96%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39079](http://purl.obolibrary.org/obo/NCIT_C39079) (Fc Epsilon Receptor I Signaling Pathway BioCarta))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39071](http://purl.obolibrary.org/obo/NCIT_C39071) (Neuronal Survival Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39069](http://purl.obolibrary.org/obo/NCIT_C39069) (ErbB3 Receptor Recycling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 39.52%


